Platanoside Inhibits Ferroptosis in Acute Lung Injury via Keap1/Nrf2/GPX4 Pathway

Study Background and Research Question

Acute lung injury (ALI) is a severe pulmonary disorder marked by high morbidity and mortality, particularly in intensive care settings, with mortality rates reaching as high as 30–40% according to the reference study. Pathologically, ALI is characterized by overwhelming inflammation, oxidative stress, and the breakdown of the alveolar–capillary barrier. Despite the use of mechanical ventilation and pharmacological interventions targeting inflammation and oxidative stress, clinical outcomes remain suboptimal due to limitations such as insufficient tissue specificity and pathway redundancy. There is an urgent need for novel therapeutic strategies that can concurrently modulate inflammation, counteract oxidative damage, and preserve cellular integrity—particularly through targeting regulated cell death modalities like ferroptosis.

Key Innovation from the Reference Study

The central innovation in the reference paper lies in uncovering the mechanism by which platanoside (PLA), a naturally occurring flavonoid glycoside, inhibits ferroptosis in ALI. Specifically, the study demonstrates that PLA induces autophagy-dependent degradation of Keap1, a key negative regulator of the antioxidant transcription factor Nrf2. This degradation relieves the suppression of Nrf2, resulting in enhanced nuclear translocation of Nrf2 and upregulation of downstream cytoprotective genes, notably glutathione peroxidase 4 (GPX4). The activation of the Nrf2/GPX4 axis leads to effective suppression of lipid peroxidation and ferroptosis, thereby protecting lung tissue from oxidative injury.

Methods and Experimental Design Insights

The study employed a combination of in vivo and in vitro approaches to delineate the mechanistic pathway of PLA action:

• Lipopolysaccharide (LPS)-induced ALI mouse models were used to mimic human acute lung injury and evaluate the therapeutic effects of PLA.
• Western blotting and immunohistochemistry quantified protein levels of Keap1, Nrf2, and GPX4 in pulmonary tissues.
• Markers of lipid peroxidation, such as 4-hydroxynonenal (4-HNE) and malondialdehyde (MDA), were measured to assess ferroptotic activity.
• Mitochondrial integrity and histopathological changes were evaluated via electron microscopy and standard histology.
• Protein-protein interaction assays and co-immunoprecipitation elucidated the impact of PLA on Keap1–p62 complex formation and autophagic flux.
• Functional assays confirmed the role of autophagy and the Keap1-p62-Nrf2 axis by using pharmacological inhibitors and siRNA knockdown strategies.

This integrated methodology provided robust evidence linking PLA's effects to the sequential modulation of autophagy, Keap1 degradation, Nrf2 activation, and GPX4-mediated antioxidant defense.

Core Findings and Why They Matter

Key findings from the study include:

• PLA treatment significantly reduced Keap1 protein levels in lung tissues of LPS-induced ALI mice, supporting enhanced autophagic degradation.
• Nrf2 nuclear translocation and GPX4 activity were markedly increased following PLA administration, leading to improved antioxidant capacity.
• Biochemical and histological analyses showed that PLA reduced lipid peroxidation (decreased 4-HNE and MDA), attenuated mitochondrial damage, and decreased inflammatory infiltration in lung tissues.
• Mechanistically, PLA promoted SQSTM1/p62-mediated autophagic degradation of Keap1, establishing a self-reinforcing feedback loop that further amplified Nrf2 and p62 expression.

These findings are significant because they position PLA as a multi-targeted agent capable of interrupting the cycle of oxidative stress and ferroptosis, which are central to the pathogenesis of ALI. By targeting the Keap1/Nrf2/GPX4 axis through autophagy, PLA offers a promising approach to overcoming the limitations of current single-pathway therapies and improving tissue-specific outcomes in oxidative stress-induced lung injury.

Comparison with Existing Internal Articles

Recent internal reviews such as "Strategic Redox Sensing: Unleashing Dihydroethidium (DHE)" and "Dihydroethidium (DHE): Gold Standard Superoxide Detection..." emphasize the importance of sensitive and specific detection of superoxide and other intracellular reactive oxygen species (ROS) in oxidative stress assays, apoptosis research, and disease modeling. These articles highlight the role of Dihydroethidium (DHE, hydroethidine) as a validated fluorescent probe for superoxide detection in live cell models, underlying its critical role in mechanistic redox biology studies. The reference study's focus on the Keap1/Nrf2/GPX4 axis in ALI complements these internal resources by providing a mechanistic link between ROS generation, ferroptosis, and antioxidant defense. While internal articles delve into the technical aspects and optimization of superoxide detection using DHE—essential for quantifying oxidative stress and validating interventions—the reference paper provides a concrete example of how modulating redox-sensitive pathways translates into therapeutic benefit in a clinically relevant disease model. Together, these bodies of evidence underscore the necessity of precise intracellular reactive oxygen species measurement and mechanistic dissection in advancing both basic and translational research on oxidative stress and cell death.

Limitations and Transferability

While the study offers compelling mechanistic insight, several limitations merit consideration:

• The in vivo experiments were conducted exclusively in murine LPS-induced ALI models. While these models recapitulate key aspects of human disease, species-specific differences may affect translational outcomes.
• The study primarily investigated acute, rather than chronic, injury scenarios. The long-term impact of PLA on lung remodeling and resolution of inflammation remains to be elucidated.
• Although PLA modulates autophagy, Keap1 degradation, and Nrf2/GPX4 activation, potential off-target effects and broader safety profiles require further exploration, especially for future clinical translation.
• Transferability to other forms of regulated cell death or oxidative stress-driven diseases (such as cardiovascular disease or neurodegeneration) is theoretically plausible via the same axis, but direct experimental evidence outside ALI is still limited.

Protocol Parameters

• LPS-induced ALI model: LPS administered intratracheally or intraperitoneally to induce acute lung injury in mice; PLA administered at predetermined dosages and time points post-LPS challenge.
• Protein quantification: Keap1, Nrf2, and GPX4 measured by Western blotting; nuclear and cytoplasmic fractions analyzed for Nrf2 translocation.
• Oxidative stress assessment: 4-HNE and MDA levels quantified in lung tissue homogenates as markers of lipid peroxidation and ferroptosis.
• Autophagic flux analysis: SQSTM1/p62 and LC3B-II levels monitored; co-immunoprecipitation assays for Keap1–p62 complex formation.
• Workflow suggestion: For redox signaling studies, validated fluorescent probes such as Dihydroethidium (DHE) can be incorporated to measure intracellular superoxide levels and evaluate oxidative stress modulation by candidate compounds.

Research Support Resources

Researchers investigating oxidative stress, ferroptosis, and redox biology in acute lung injury or related pathologies may benefit from validated tools for intracellular reactive oxygen species measurement. Dihydroethidium (DHE) (SKU C3807), also known as hydroethidine, is a cell-permeable superoxide detection fluorescent probe compatible with live cell imaging and quantitative assays. As highlighted in recent reviews, DHE enables sensitive detection of superoxide anions and can be integrated into workflows for oxidative stress assays, apoptosis research, and cardiovascular disease research. For further mechanistic dissection and protocol guidance, see the internal article "Strategic Redox Sensing: Unleashing Dihydroethidium (DHE)".